WESTFORD, Mass. and BURLINGTON, Mass., April 24, 2013 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO) and Palomar Medical Technologies, Inc. (NASDAQ: PMTI) today announced that the 2013 Annual Meeting of Cynosure Stockholders and the ...
BURLINGTON, Mass., May 2, 2013 (GLOBE NEWSWIRE) -- Palomar Medical Technologies, Inc. (Nasdaq:PMTI), a global leader in laser and other light-based systems for aesthetic treatments, today announced financial results for the first quarter ended March ...
San Diego, CA -- (SBWIRE) -- 04/23/2013 -- An investor in shares of Palomar Medical Technologies Inc (NASDAQ:PMTI) filed a lawsuit in effort to halt the proposed takeover of Palomar Medical Technologies Inc by Cynosure, Inc for a value of $13.65 per ...
Wall Street Journal (press release) - Apr 26, 2013
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Palomar Medical Technologies Inc. in Connection With Sale of Company to Cynosure Inc. Press Release. Email; Printer Friendly; Share: ...
Sterling Medical Associates Inc., Cincinnati, Ohio, was awarded a firm-fixed-price contract with a maximum value of $14,335,637 for healthcare services at Army and Air Force facilities located in Europe.
On an adjusted basis, excluding costs associated with the Company's pending acquisition of Palomar Medical Technologies, Inc., net income for the first quarter of 2013 was $2.1 million, or $0.12 per diluted share. Net income under GAAP (Generally ...
San Francisco Chronicle (press release) - May 15, 2013
Biscotti Inc., a technology leader in high-definition video calling products and cloud-based services for the home and office, today announced its multiparty calling service.
The figures are provided by Thomson Reuters I/B/E/S. **** Company Name Ticker Qtr Industry Curr EPS Est EPS Act Diff EPS Rev Est Rev Act Diff Rev ABIOMED INC Q4 MEDICAL SUPPLIES USD 0.07 0.09 0.02 42.0 43.7 1.7 ACI WORLDWIDE INC Q1 ... INTERNATIONAL ...
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. To see all exchange delays, please see disclaimer.